Levee Medical Completes Oversubscribed $12M+ Financing to Support PMA as ARID II Trial Progresses

by Kristen Lomas | Feb 17, 2026 | Press Releases

Durham, N.C. — February 17, 2026 — Levee Medical, a medical device innovator focused on improving outcomes for men undergoing prostate cancer surgery, today announced the close of an additional round of financing totaling over $12 million, completed ahead of schedule...

Levee Medical® Announces Landmark ARID II Trial Nears Halfway Enrollment Milestone and Publication of ARID Clinical Results in World Journal of Urology

by Kristen Lomas | Jan 22, 2026 | Press Releases

Durham, N.C. — January 20, 2026 — Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its Voro® Urologic Scaffold, highlighted by...

The Hidden Cost of Stress Urinary Incontinence on Men’s Lives

by Kristen Lomas | Jan 22, 2026 | Press Releases

Stress urinary incontinence (SUI) is a common consequence of prostate surgery, especially after radical prostatectomy. According to Dr. Melissa Kaufman, a leading reconstructive urologist at Vanderbilt University, its impact on men’s quality of life is profound — and...

American Medical Association Grants Levee Medical Category III CPT Code for Placement of Voro® Urologic Scaffold

by Kristen Lomas | Dec 15, 2025 | Press Releases

Durham, NC – October 14, 2025 – Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced that the American Medical Association’s (AMA) CPT Editorial Panel has approved a Category III CPT add-on code...

Levee Medical® Announces Issuance of Foundational U.S. Patent Covering the Voro® Urologic Scaffold

by Kristen Lomas | Dec 15, 2025 | Press Releases

Patent issuance strengthens IP portfolio as ARID II pivotal trial advances with rapid site activation and patient enrollment Durham, N.C. — September 8, 2025 Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients,...

Levee Medical® Announces First Patient Enrolled in ARID II IDE Pivotal Trial

by Kristen Lomas | Apr 24, 2025 | Press Releases

Durham, NC – April 24, 2025 – Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced the enrollment of the first patient in its landmark ARID II pivotal trial. This marks a significant milestone in...